Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Blood Advances
Published September 30, 2026
Novel KIR2DS4:HLA-B*35 interaction predicts HLA-B*35 positive patient survival post hematopoietic...
October 1, 2026
Medspoke
Medspoke
Blood Advances
Published September 30, 2026
00:00
--:--
Forimtamig, a GPRC5DxCD3 bispecific antibody with a novel 2:1 format, in relapsed/refractory mult...
October 1, 2026
Share
Forimtamig, a GPRC5DxCD3 bispecific antibody with a novel 2:1 format, in relapsed/refractory multiple myeloma.
https://www.medspoke.co/channel_journal?id=683&tap_id=14865
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Blood Advances
Published September 30, 2026
Late Venous Thromboembolic Events in Survivors of Childhood Cancer: A Report from the St Jude Lif...
October 1, 2026
Why are you reporting this TALK?
